Study | Country | Type of literature | Population | Intervention | Comparator | Perspective | Time horizon | Type of analysis | Methods |
MSAC 200635 | AUS | HTA report | localised PC | RARP | ORP | Societal | 10 years | CUA | Decision Tree |
O'Malley 200736 | AUS | Journal article | PC | RARP | ORP | Payer* | * | CUA | Cohort based |
Hohwü 201119 | DEN | Journal article | localised PC | RARP | ORP | Societal | 1 year | CEA | Cohort based |
HIQA 201138 | IRE | HTA report | PC T2-T3 | RARP | Mix of ORP and LRP | Payer | 5 years | CUA | Markov Model |
Close 201316 /Ramsay 201240 | UK | Journal /HTA report | localised PC | RARP | LRP | Payer | 10 years | CUA | Discrete event simulation |
Cooperberg 201317 | USA | Journal article | localised PC | RARP | ORP, LRP+other† | Payer | Lifetime | CUA | Markov Model |
Teljeur 201432 | IRE | Journal article | RP | RARP | ORP, LRP | Payer | Lifetime* | CUA | * |
Ratchanon 201531 | THA | Journal article | localised PC | RARP | LRP | Health system | 10 years | CUA | Decision Tree |
AHT 201733 | CAN | HTA report | localised PC | RARP | ORP+others‡ | Payer | 9 years | CUA | Markov Model |
HQO 201718 | CAN | HTA report | localised PC | RARP | ORP | Payer | 1 year | CUA | Markov Model |
Parackal 202037 | CAN | Journal article | localised PC | RARP | ORP | Payer | 10 years | CUA | Markov Model |
de Oliveira 202134 | BRA | Journal article | localised PC | RARP | ORP | Hospital | 5 years | CUA | Cohort based |
*Not clearly stated
†IMRT, BT, 3DCRT, EBRT+BT.
‡Beam radiotherapy, brachytherapy and cryoablation.
AUS, Australia; BRA, Brazil; BT, brachytherapy; CAN, Canada; CEA, cost-effectiveness analysis; CUA, cost–utility analysis; 3DCRT, three-dimensional conformal radiation therapy; DEN, Denmark; EBRT, external beam radiation therapy; IMRT, Intensity-modulated radiation therapy; IRE, Ireland; LRP, local radical prostatectomy; ORP, open radical prostatectomy; PC, prostate cancer; RARP, robotic-assisted radical prostatectomy; RP, radical prostatectomy; THA, Thailand.